Jan 15, 2020

IBM and Samsung top U.S. patent list

Go deeper

A tale of two drug patent cases

Biogen scored a major patent win with its multiple sclerosis drug. Photo: John Tlumacki/The Boston Globe via Getty Images

The U.S. Patent and Appeal Board this week handed down mixed rulings in a pair of important cases involving drug patents.

Why it matters: The patent system is the foundation of drug companies' ability to keep their prices high, and these specific rulings will affect access and cost for two drugs that treat serious conditions — HIV and multiple sclerosis.

Go deeperArrowFeb 7, 2020 - Health

U.S.-China trade deal could be good for Big Pharma

Illustration: Aïda Amer/Axios

President Trump's new trade agreement with China includes patent protections that could be a big boon to drug companies.

Why it matters: China's enormous population is a lucrative market for pharma, and the country is also actively trying to build up its own domestic drug industry. But it's not guaranteed that China will actually abide by the agreement.

Go deeperArrowJan 16, 2020

Peloton goes to court over "connected fitness"

Photo: Scott Heins/Getty Images.

Peloton is going to court to try to protect its head start in “connected fitness" as challengers move in, the Wall Street Journal reports.

Why it matters: "It’s a premise that has powered many upstarts in recent years: Uber is a tech company, not a taxi company; WeWork's a tech company, not a real-estate company; Tesla’s a tech company, not a car company," the Journal notes.

Go deeperArrowJan 20, 2020